Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
13342 | 779 | 36.4 | 69% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
389 | 16325 | RHEUMATOID ARTHRITIS//RHEUMATOLOGY//RHEUMATOL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | COPCORD | Author keyword | 50 | 88% | 3% | 23 |
2 | RHEUMATIC MUSCULOSKELETAL DISORDERS | Author keyword | 3 | 100% | 0% | 3 |
3 | COMMUNITY BASED EPIDEMIOL PREVENT TREATMENT RHE | Address | 2 | 67% | 0% | 2 |
4 | NORTH AMERICAN NATIVES | Author keyword | 2 | 67% | 0% | 2 |
5 | RHEUMATIC COMPLAINTS | Author keyword | 2 | 67% | 0% | 2 |
6 | SEROJA RHEUMAT | Address | 2 | 67% | 0% | 2 |
7 | UNIT DR MARIO ALVIZOURI MUNOZ | Address | 2 | 67% | 0% | 2 |
8 | YUKIOKA HOSP | Address | 2 | 67% | 0% | 2 |
9 | CLIN UNIV REUMATOL | Address | 1 | 50% | 0% | 2 |
10 | COPCORD METHODOLOGY | Author keyword | 1 | 100% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CORE QUESTIONNAIRE | 41 | 90% | 2% | 18 |
2 | WHO ILAR COPCORD | 21 | 48% | 4% | 32 |
3 | PHILIPPINE VILLAGE | 21 | 78% | 2% | 14 |
4 | SWEDISH EIRA | 13 | 67% | 2% | 12 |
5 | LEAGUE AGAINST RHEUMATISM | 11 | 100% | 1% | 6 |
6 | HEAVY CIGARETTE SMOKING | 6 | 80% | 1% | 4 |
7 | AFRICAN NEGRO POPULATION | 5 | 39% | 1% | 11 |
8 | DEVELOPING RHEUMATOID ARTHRITIS | 4 | 67% | 1% | 4 |
9 | VALIDATED ARABIC VERSION | 4 | 75% | 0% | 3 |
10 | 1987 REVISED CRITERIA | 3 | 26% | 1% | 10 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: A systematic review | 2006 | 160 | 41 | 71% |
Body mass index and the risk of rheumatoid arthritis: a systematic review and dose-response meta-analysis | 2015 | 1 | 39 | 51% |
Epidemiology of rheumatic musculoskeletal disorders in the developing world | 2008 | 39 | 65 | 75% |
The protective effect of alcohol on developing rheumatoid arthritis: a systematic review and meta-analysis | 2013 | 10 | 41 | 49% |
Risk factors for the development of rheumatoid arthritis | 2006 | 58 | 52 | 75% |
Environmental influences on risk for rheumatoid arthritis | 2009 | 39 | 37 | 57% |
Osteoarthritis of the knees in the COPCORD world | 2011 | 10 | 36 | 69% |
Sex-specific environmental influences on the development of autoimmune diseases | 2013 | 10 | 83 | 41% |
Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop | 2012 | 54 | 171 | 19% |
Oral contraceptives and rheumatoid arthritis: Results from a primary care-based incident case-control study | 1997 | 64 | 19 | 89% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | COMMUNITY BASED EPIDEMIOL PREVENT TREATMENT RHE | 2 | 67% | 0.3% | 2 |
2 | SEROJA RHEUMAT | 2 | 67% | 0.3% | 2 |
3 | UNIT DR MARIO ALVIZOURI MUNOZ | 2 | 67% | 0.3% | 2 |
4 | YUKIOKA HOSP | 2 | 67% | 0.3% | 2 |
5 | CLIN UNIV REUMATOL | 1 | 50% | 0.3% | 2 |
6 | EPIDEMIOL RHEUMAT DIS | 1 | 100% | 0.3% | 2 |
7 | RHEUMATOLUNIT AUTOIMMUN IMMUNE REGULAT | 1 | 100% | 0.3% | 2 |
8 | RHEUMAT DIS EPIDEMIOL SECT | 1 | 33% | 0.3% | 2 |
9 | UMAE 25 | 1 | 33% | 0.3% | 2 |
10 | BRIGHAM WOMENS HOSPSECT CLIN SCI | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000237351 | SHARED EPITOPE//HLA DRB1//HLA DR4 |
2 | 0.0000184487 | CITRULLINATION//PEPTIDYLARGININE DEIMINASE//ANTIPERINUCLEAR FACTOR |
3 | 0.0000129649 | HERBERT KRAUSS KLIN//KLIN PHYSIOTHER IE NATURHEILVERFAHREN//INTERNAL COMPLEMENTARY MED |
4 | 0.0000124821 | WORK DISABILITY//WORK INSTABILITY//CARDIOVASC DIS SPECIAL MED |
5 | 0.0000120393 | MOTHERS RHEUMAT DIS//PREGNANCY RHEUMAT DIS//LUPUS PREGNANCY |
6 | 0.0000110587 | ABATACEPT//TOCILIZUMAB//DISEASE MODIFYING ANTIRHEUMATIC DRUGS |
7 | 0.0000108719 | ANTI TNF ALPHA ANTIBODY INFLIXIMAB//EPIDEMIOL COMPUTAT BIOL//RHEUMATOID CACHEXIA |
8 | 0.0000103694 | EXPT RHEUMATOL NEUROENDOCRINOIMMUNOL//NEUROENDOCRINOIMMUNOL//MODIFIED RELEASE PREDNISONE |
9 | 0.0000093230 | AIMS2//HEALTH ASSESSMENT QUESTIONNAIRE//MDHAQ |
10 | 0.0000089170 | PTPN22//PROTEIN TYROSINE PHOSPHATASE NONRECEPTOR 22//IRF5 |